Online citations, reference lists, and bibliographies.
← Back to Search

Failure Patterns After Hemithoracic Pleural Intensity Modulated Radiation Therapy For Malignant Pleural Mesothelioma.

A. Rimner, D. Spratt, M. Zauderer, K. Rosenzweig, A. Wu, Amanda L. Foster, E. Yorke, P. Adusumilli, V. Rusch, L. Krug
Published 2014 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
PURPOSE We previously reported our technique for delivering intensity modulated radiation therapy (IMRT) to the entire pleura while attempting to spare the lung in patients with malignant pleural mesothelioma (MPM). Herein, we report a detailed pattern-of-failure analysis in patients with MPM who were unresectable or underwent pleurectomy/decortication (P/D), uniformly treated with hemithoracic pleural IMRT. METHODS AND MATERIALS Sixty-seven patients with MPM were treated with definitive or adjuvant hemithoracic pleural IMRT between November 2004 and May 2013. Pretreatment imaging, treatment plans, and posttreatment imaging were retrospectively reviewed to determine failure location(s). Failures were categorized as in-field (within the 90% isodose line), marginal (<90% and ≥50% isodose lines), out-of-field (outside the 50% isodose line), or distant. RESULTS The median follow-up was 24 months from diagnosis and the median time to in-field local failure from the end of RT was 10 months. Forty-three in-field local failures (64%) were found with a 1- and 2-year actuarial failure rate of 56% and 74%, respectively. For patients who underwent P/D versus those who received a partial pleurectomy or were deemed unresectable, the median time to in-field local failure was 14 months versus 6 months, respectively, with 1- and 2-year actuarial in-field local failure rates of 43% and 60% versus 66% and 83%, respectively (P=.03). There were 13 marginal failures (19%). Five of the marginal failures (38%) were located within the costomediastinal recess. Marginal failures decreased with increasing institutional experience (P=.04). Twenty-five patients (37%) had out-of-field failures. Distant failures occurred in 32 patients (48%). CONCLUSIONS After hemithoracic pleural IMRT, local failure remains the dominant form of failure pattern. Patients treated with adjuvant hemithoracic pleural IMRT after P/D experience a significantly longer time to local and distant failure than patients treated with definitive pleural IMRT. Increasing experience and improvement in target delineation minimize the incidence of avoidable marginal failures.
This paper references
10.1097/JTO.0b013e3181a5292c
Patterns of Local and Nodal Failure in Malignant Pleural Mesothelioma After Extrapleural Pneumonectomy and Photon-Electron Radiotherapy
V. Gupta (2009)
10.3109/02841869709001287
Altered fractionation of hemithorax irradiation for pleural mesothelioma and failure patterns after treatment.
L. R. Holsti (1997)
10.1016/j.ijrobp.2007.10.010
Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer.
Gordon O. Schoenfeld (2008)
10.1016/S0167-8140(01)00453-4
Definition of gross tumor volume in lung cancer: inter-observer variability.
J. van de Steene (2002)
10.1097/JTO.0b013e31821ea60c
Radiation Therapy Definitions and Reporting Guidelines for Thymic Malignancies
D. Gomez (2011)
10.1097/JTO.0b013e31827740f0
Patterns of Failure, Toxicity, and Survival after Extrapleural Pneumonectomy and Hemithoracic Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma
D. Gomez (2013)
10.1016/J.IJROBP.2007.02.047
Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy.
A. Allen (2007)
10.1016/j.jtcvs.2007.10.054
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
R. Flores (2008)
10.1016/j.lungcan.2013.10.013
Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up.
E. Minatel (2014)
10.1016/S1470-2045(11)70149-8
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
T. Treasure (2011)
10.1016/J.IJROBP.2005.03.041
Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma.
V. Gupta (2005)
10.3978/j.issn.2225-319X.2012.10.08
Pleurectomy/decortication, chemotherapy, and intensity modulated radiation therapy for malignant pleural mesothelioma: rationale for multimodality therapy incorporating lung-sparing surgery.
M. Zauderer (2012)
10.1002/hed.21677
Marginal recurrences after selective targeting with intensity‐modulated radiotherapy for oral tongue cancer
S. Damast (2012)
10.3978/j.issn.2225-319X.2012.10.07
Novel radiation therapy approaches in malignant pleural mesothelioma.
A. Rimner (2012)
10.1016/j.ijrobp.2011.09.027
Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma.
K. Rosenzweig (2012)
10.1097/JTO.0000000000000099
Failure Patterns Relative to Radiation Treatment Fields for Stage II–IV Thymoma
A. Rimner (2014)
10.1067/MTC.2001.116560
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
V. Rusch (2001)
10.1016/S0360-3016(03)00287-6
Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma.
S. Yajnik (2003)



This paper is referenced by
10.1016/j.ijrobp.2017.04.025
Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma.
E. Yorke (2017)
10.1016/j.canrad.2016.09.009
Radiation therapy for malignant pleural mesothelioma.
K. Rosenzweig (2017)
10.1007/s11864-014-0314-4
Local and Systemic Therapies for Malignant Pleural Mesothelioma
D. Gomez (2014)
10.1016/j.canrad.2017.05.007
High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment.
E. Parisi (2017)
10.3978/j.issn.2225-319X.2012.10.07
Novel radiation therapy approaches in malignant pleural mesothelioma.
A. Rimner (2012)
10.1016/j.jtcvs.2015.10.038
SMART or simply bold?
V. Rusch (2016)
10.1016/j.cllc.2019.08.008
Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience.
D. Franceschini (2019)
10.1016/j.cllc.2018.08.019
Moderately Hypofractionated Helical IMRT, FDG–PET/CT‐guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs
A. Fodor (2019)
10.1016/j.ijrobp.2015.06.029
Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.
E. Minatel (2015)
10.1200/JCO.2016.67.2675
Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.
A. Rimner (2016)
10.1586/17476348.2016.1171147
The role of thoracic surgery in the management of mesothelioma: an expert opinion on the limited evidence
P. Bertoglio (2016)
10.1016/j.prro.2018.12.008
Dosimetric Correlates of Pulmonary Toxicity in Patients with Malignant Pleural Mesothelioma Receiving Radiation Therapy to the Intact Lungs.
M. Thompson (2019)
10.1007/s00066-017-1108-y
Does selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation?
A. Botticella (2017)
10.1007/s00330-018-5937-6
Computed tomography features of local pleural recurrence in patients with malignant pleural mesothelioma treated with intensity-modulated pleural radiation therapy
D. Halpenny (2018)
10.1063/1.4900962
Radioluminescence characterization of in situ x-ray nanodosimeters: Potential real-time monitors and modulators of external beam radiation therapy.
Jeffrey S. Souris (2014)
10.1016/j.jtcvs.2015.09.129
Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma.
M. D. de Perrot (2016)
10.1136/thoraxjnl-2017-211321
British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
I. Woolhouse (2018)
10.1016/j.jtho.2019.09.199
Response to Letter to Editor from Fodor et al., "The 'Radical' Palliation That Increases Survival in Malignant Pleural Mesothelioma".
D. Gómez (2019)
10.1016/J.THORSURG.2020.08.006
Radiation Therapy for Malignant Pleural Mesothelioma.
K. Rosenzweig (2020)
10.1080/0284186X.2016.1234066
Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study
A. Botticella (2016)
Volumetric-modulated arc therapy for malignant pleural mesothelioma after pleurectomy / decortication
V. Dumane (2016)
10.1186/s13014-015-0575-5
Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy
C. Thieke (2015)
10.1016/j.jtho.2017.02.026
Improved Outcomes with Modern Lung‐Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma
F. Shaikh (2017)
10.1016/j.prro.2020.05.004
Consensus Statement on Proton Therapy in Mesothelioma.
J. Zeng (2020)
10.2217/LMT.15.15
Optimizing hemithoracic pleural intensity-modulated radiation therapy for malignant pleural mesothelioma
F. Shaikh (2015)
10.1016/j.jtho.2018.02.021
Progress in the Management of Malignant Pleural Mesothelioma in 2017
Amanda J McCambridge (2018)
10.1007/978-3-319-28761-4_20
Modern Radiotherapy Techniques in Malignant Pleural Mesothelioma
G. Ozyigit (2016)
10.1016/j.jtho.2018.02.021
State of the Art : Advances in Malignant Pleural Mesothelioma in 2017
Amanda J McCambridge (2018)
10.1016/S1470-2045(15)00208-9
Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
R. Stahel (2015)
10.1111/1754-9485.12636
High‐dose palliative radiotherapy for malignant pleural mesothelioma
F. Foroudi (2017)
10.1016/j.prro.2015.07.010
Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma.
A. Kishan (2015)
10.1080/17476348.2019.1679119
Types of surgery post-neoadjuvant chemotherapy for pleural mesothelioma
K. Kuribayashi (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar